Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Quantifying Methylated Purine Nucleosides via Stable Isotope
2026-06-16
Zhang et al. present a robust isotope-diluted UHPLC–MS/MS workflow to quantify ten methylated purine nucleosides, addressing longstanding analytical challenges in modified nucleoside detection. This sensitive method facilitates studies on RNA modification dynamics and purine metabolism, with implications for biomarker discovery in clinical research.
-
Foxp1 Restricts EndMT and Valvular Calcification in CKD Mode
2026-06-16
This study demonstrates that endothelial-specific overexpression of Foxp1 suppresses valvular calcification in chronic kidney disease by inhibiting Notch-driven endothelial-to-mesenchymal transition. The findings highlight Foxp1 as a potential regulatory target for mitigating cardiovascular complications in CKD and refine mechanistic understanding of PTH-induced calcific remodeling.
-
RNA Polymerase II Degradation Drives Oocyte Chromatin Reorga
2026-06-15
This study demonstrates that targeted degradation of RNA polymerase II is both necessary and sufficient for the critical transition in oocyte chromatin architecture that underlies successful maternal-to-zygotic transition. By mapping nuclear changes and employing innovative protein degradation techniques, the authors redefine mechanistic understanding of mammalian oogenesis and early embryo development.
-
CCR5-Positive Extracellular Vesicles Drive RA Pathogenesis
2026-06-15
This study reveals the pivotal role of CCR5-expressing extracellular vesicles from synovial fibroblasts in exacerbating joint damage in rheumatoid arthritis (RA). By demonstrating that targeted CCR5 inhibition—using Maraviroc or genetic manipulation—mitigates inflammation and bone destruction, the work establishes CCR5 as a promising therapeutic target for RA.
-
Luminescent ATP Detection Assay Kit: High-Sensitivity Cellul
2026-06-14
The Luminescent ATP Detection Assay Kit enables reproducible, ultrasensitive quantification of ATP in biological samples using firefly luciferase chemistry. Its robust performance, broad dynamic range, and user-friendly protocol make it a standard tool for intracellular ATP level detection and energy metabolism studies.
-
Machine Learning Predicts Optimal Ionizable Lipids for mRNA
2026-06-13
This study pioneers the use of machine learning to predict the performance of ionizable cationic liposome-based lipid nanoparticles (LNPs) for mRNA vaccine delivery. The research demonstrates that computational models can reliably identify optimal lipid structures, exemplified by the superior in vivo efficacy of Dlin-MC3-DMA, thus streamlining formulation development.
-
Veratridine: Voltage-Gated Sodium Channel Opener in Research
2026-06-12
Veratridine stands out as a voltage-gated sodium channel opener, enabling precise modulation of excitability in neural and cancer models. Its unique mechanism and validated workflows support cutting-edge sodium channel dynamics research and high-throughput screening for channel modulators.
-
Piperine Modulates STAT3 Ser727 to Attenuate Hepatic Fibrosi
2026-06-12
This study demonstrates that piperine, a major component of Piper nigrum, suppresses hepatic fibrogenesis and inflammation by selectively inhibiting STAT3 phosphorylation at Ser727. The findings reveal a targeted molecular mechanism and identify piperine as a promising candidate for hepatic fibrosis intervention.
-
Cy3-UTP: Illuminating Multivalent rRNA Interactions in Nucle
2026-06-11
Explore how Cy3-UTP enables precise fluorescent RNA labeling to investigate multilayered nucleolar structures via rRNA expansion segments. This article uniquely bridges molecular probe design with cutting-edge insights from nucleolar architecture research, offering advanced applications in RNA-protein interaction studies.
-
Deciphering Mitochondrial Permeability: Deep Insights with t
2026-06-11
Discover how the Mitochondrial Permeability Transition Pore Assay Kit enables precise, mechanism-driven insights into mitochondrial membrane dynamics and intrinsic apoptosis. This article uniquely bridges advanced cell death research with practical, quantitative assay strategies.
-
Anisomycin as a JNK Agonist: Beyond Apoptosis to Synaptic Pl
2026-06-10
Explore Anisomycin, a potent JNK agonist, in the context of both apoptosis and emerging roles in synaptic plasticity. This article offers a uniquely deep analysis, bridging cancer research and neuroscience through mechanistic insights and practical assay guidance.
-
Fe3O4@ZIF-8 Nanoparticles: Dual Action for Jaw Osteomyelitis
2026-06-10
This study presents multifunctional Fe3O4@ZIF-8 nanoparticles designed to address jaw osteomyelitis by combining potent, pH-triggered antibacterial activity with bone regeneration. The dual-function nanoplatform overcomes persistent infection and antibiotic resistance, offering a promising strategy for translational bone infection therapy.
-
Phenylmethanesulfonyl Fluoride (PMSF): Precision in Protease
2026-06-09
Explore how Phenylmethanesulfonyl fluoride (PMSF) enables precise serine protease inhibition in protein extraction, with a focus on its critical role in inflammation and SARS-CoV-2 macrophage infection models. This article uniquely bridges mechanistic insight and practical protocol design for robust, reproducible research.
-
BMS 599626 Dihydrochloride: EGFR and ErbB2 Inhibitor Workflo
2026-06-09
BMS 599626 dihydrochloride stands out as a potent, selective EGFR and ErbB2 inhibitor, enabling precise cancer cell proliferation inhibition and reliable tumor growth suppression in xenograft models. This article delivers advanced protocols, troubleshooting strategies, and cross-referenced insights to empower translational oncology, senescence research, and robust assay optimization.
-
Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera
2026-06-08
This study introduces a new series of anthraquinone-derived, allosteric PDK4 inhibitors, with compound 8c demonstrating strong in vitro potency and promising efficacy in metabolic, allergic, and cancer models. The work advances metabolic disease research by providing structurally validated, metabolically stable PDK4-targeting scaffolds with translational relevance.